Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Mandiri Persero Tbk (BMRI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank Mandiri Persero TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Mandiri Persero Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Mandiri Persero Tbk trades at Rp4,200 (market cap 384.38T, 145.28M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Bank Mandiri Persero Tbk is far larger — about 2296.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Mandiri Persero Tbk is more actively traded (145.28M versus 71K). Which is the better fit depends on your goals.

BMRIOBAT
Market Cap
384.38T167.37B
Volume
145.28M71K
Lot
1.45M710
Turnover
613.36B17.51M
Average Price
4,221.85246.63
Value
613.36B17.51M
Indicative Equilibrium Price
4,200246
Indicative Equilibrium Volume
138.7K1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMRI
View details
OBAT
View details

About Bank Mandiri Persero Tbk

Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.

Read more on BMRI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT